TABLE 1.
Alive, N = 425 | Dead, N = 94 | Censored, N = 19 | Overall population, N = 538 | Missing | |
---|---|---|---|---|---|
Continuous covariates – Median [Q1;Q3] | |||||
Age (years) | 64 [54;70] | 71 [64;78] | 72 [57;74] | 65 [56;72] | 0 |
Weight (kg) | 85 [74;97] | 80 [70;91] | 80 [68;90] | 84 [73;96] | 1 |
Height (cm) | 170 [165;176] | 170 [164;174] | 168 [160;177] | 170 [164;176] | 6 |
BMI (kg/m2) | 29 [26;33] | 28 [25;31] | 28 [27;33] | 29 [26;33] | 6 |
Charlson index | 2 [1;2] | 3 [1;4] | 1 [1;2] | 2 [1;3] | 0 |
Time between first symptoms and ICU admission (days) | 9 [7;11] | 7 [4;9] | 10 [3;11] | 9 [6;11] | 10 |
Length of hospital stay (days) | 19 [11;41] | 14 [8;21] | 10 [8;16] | 18 [11;34] | 5 |
Length of ICU stay (days) | 8 [4;21] | 12 [7;19] | 7 [3;10] | 9 [5;20] | 1 |
SOFA score | 2 [1;4] | 4 [2;7] | 1 [0;4.5] | 3 [1;5] | 0 |
SAPSII score | 30 [22;37] | 38 [30;47] | 30 [22;44] | 31 [24;40] | 0 |
Glasgow coma scale | 15 [15;15] | 15 [15;15] | 15 [14.5;15] | 15 [15;15] | 1 |
Categorical covariates – n (%) | |||||
Male gender | 298 (70) | 75 (80) | 19 (53) | 383 (71) | 0 |
Mechanical ventilation before 3rd day in ICU | 122 (29) | 45 (48) | 6 (32) | 173 (32) | 0 |
Mac Cabe index | 209 | ||||
Stage 1 a | 1 (0.4) | 3 (5.3) | 0 (0) | 4 (1) | |
Stage 2 b | 20 (7.6) | 10 (18) | 2 (25) | 32 (10) | |
Stage 3 c | 243 (92) | 44 (77) | 6 (75) | 293 (89) | |
Preexisting immunological disease | 32 (7.5) | 17 (18) | 0 (0) | 49 (9) | 0 |
Treatment by ARA II d | 59 (14) | 15 (16) | 2 (11) | 76 (14) | 0 |
Origin | 0 | ||||
Exterior | 260 (61) | 60 (64) | 12 (63) | 332 (62) | |
COVID unit | 75 (18) | 8 (9) | 1 (5) | 84 (16) | |
Hospital e | 76 (18) | 24 (26) | 6 (32) | 106 (20) | |
Other | 14 (3) | 2 (2) | 0 (0) | 16 (3) | |
ARDS f | 165 (41) | 69 (78) | 8 (42) | 242 (47) | 26 |
Nosocomial infections | 117 (32) | 45 (57) | 5 (26) | 167 (36) | 79 |
Vital status at day 90 | |||||
Alive | 353 (93) | 0 (0) | 0 (0) | 353 (74) | 64 |
Dead | 27 (7) | 94 (100) | 0 (0) | 121 (26) | |
COVID wave g | 0 | ||||
1 | 51 (12) | 16 (17) | 0 (0) | 67 (12) | |
2 | 142 (33) | 36 (38) | 8 (42) | 186 (35) | |
3 | 142 (33) | 21 (22) | 9 (47) | 172 (32) | |
4 | 90 (21) | 21 (22) | 2 (11) | 113 (21) |
Disease deadly within a year.
Life threatening disease at 5 years.
No threatening disease.
Angiotensin II Receptor Antagonist.
Except COVID unit.
Acute Respiratory Distress Syndrome.
COVID wave: 1: from March 2020 to July 5th 2020. 2: from July 6th 2020 to January 3rd 2021. 3: from January 4th 2021 to July 4th 2021. 4: after July 5th 2021.